Table 2.
All cancers |
Leukaemia |
Lymphoma |
Malignant CNS tumours |
Other cancers |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cases | Incidence per million person-years (95% CI) | Annual change (95% CI) | Cases | Incidence per million person-years (95% CI) | Annual change (95% CI) | Cases | Incidence per million person-years | Annual change (95% CI) | Cases | Incidence per million person-years (95% CI) | Annual change (95% CI) | Cases | Incidence per million person-years (95% CI) | Annual change (95% CI) | |
East | 8041 | 169·6 (165·9 to 173·4) | 1·23% (0·62 to 1·84) | 1023 | 21·6 (20·3 to 22·9) | 1·79% (0·43 to 3·17) | 2096 | 44·2 (42·3 to 46·1) | 0·68% (0·10 to 1·26) | 749 | 15·8 (14·7 to 16·9) | −0·09% (−1·23 to 1·07) | 4173 | 88·0 (85·4 to 90·7) | 1·65% (0·77 to 2·54) |
North | 15 207 | 167·2 (164·5 to 169·8) | 0·62% (0·28 to 0·96) | 2192 | 24·1 (23·1 to 25·1) | 0·08% (−0·62 to 0·78) | 3981 | 43·8 (42·4 to 45·1) | 0·82% (0·12 to 1·52) | 1358 | 14·9 (14·1 to 15·7) | −0·91% (−2·48 to 0·68) | 7676 | 84·4 (82·5 to 86·3) | 0·97% (0·65 to 1·28) |
South | 3941 | 197·0 (190·8 to 203·1) | 1·78% (1·36 to 2·20) | 501 | 25·0 (22·8 to 27·2) | 2·03% (0·66 to 3·42) | 1244 | 62·2 (58·7 to 65·6) | 2·13% (1·26 to 3·01) | 288 | 14·4 (12·7 to 16·1) | 0·94% (−0·71 to 2·62) | 1908 | 95·4 (91·1 to 99·6) | 1·61% (0·80 to 2·42) |
West | 7949 | 193·7 (189·4 to 197·9) | 1·08% (0·72 to 1·43) | 986 | 24·0 (22·5 to 25·5) | 1·35% (0·33 to 2·38) | 2125 | 51·8 (49·6 to 54·0) | 1·59% (0·67 to 2·52) | 588 | 14·3 (13·2 to 15·5) | −0·10% (−1·43 to 1·25) | 4250 | 103·5 (100·4 to 106·6) | 0·95% (0·51 to 1·39) |
Europe | 35 138 | 176·2 (174·4 to 178·0) | 0·96% (0·73 to 1·19) | 4702 | 23·6 (22·9 to 24·3) | 0·93% (0·49 to 1·37) | 9446 | 47·4 (46·4 to 48·3) | 1·04% (0·65 to 1·44) | 2983 | 15·0 (14·4 to 15·5) | −0·40% (−1·19 to 0·39) | 18 007 | 90·3 (89·0 to 91·6) | 1·17% (0·82 to 1·53) |